Skip to main content
. 2019 Oct 31;8(10):3173–3178. doi: 10.4103/jfmpc.jfmpc_522_19

Figure 2.

Figure 2

Bar chart showing changes in irritable bowel syndrome quality of life (IBS-QoL) score in the two study groups. Note that the modest increase in IBS-QoL was statistically significant in mebeverine arm but not in placebo arm